Community Health Systems, Inc. (FRA:CG5)

Community Health Systems Statistics

Total Valuation

FRA:CG5 has a market cap or net worth of EUR 404.50 million. The enterprise value is 10.03 billion.

Market Cap	404.50M
Enterprise Value	10.03B

Important Dates

The last earnings date was Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	133.87M
Shares Outstanding	n/a
Shares Change (YoY)	+2.20%
Shares Change (QoQ)	+1.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	92.27M

Valuation Ratios

The trailing PE ratio is 0.93.

PE Ratio	0.93
Forward PE	n/a
PS Ratio	0.04
PB Ratio	-0.57
P/TBV Ratio	n/a
P/FCF Ratio	2.28
P/OCF Ratio	0.87
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.82, with an EV/FCF ratio of 56.62.

EV / Earnings	23.14
EV / Sales	0.95
EV / EBITDA	6.82
EV / EBIT	10.83
EV / FCF	56.62

Financial Position

The company has a current ratio of 1.46

Current Ratio	1.46
Quick Ratio	1.13
Debt / Equity	n/a
Debt / EBITDA	6.41
Debt / FCF	53.09
Interest Coverage	1.24

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	4.96%
Return on Invested Capital (ROIC)	10.05%
Return on Capital Employed (ROCE)	9.84%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	210,564
Profits Per Employee	8,584
Employee Count	52,500
Asset Turnover	0.92
Inventory Turnover	22.28

Taxes

In the past 12 months, FRA:CG5 has paid 40.88 million in taxes.

Income Tax	40.88M
Effective Tax Rate	6.63%

Stock Price Statistics

The stock price has increased by +0.66% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+0.66%
50-Day Moving Average	2.75
200-Day Moving Average	2.78
Relative Strength Index (RSI)	63.63
Average Volume (20 Days)	446

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.83

Income Statement

In the last 12 months, FRA:CG5 had revenue of EUR 10.63 billion and earned 433.52 million in profits. Earnings per share was 3.21.

Revenue	10.63B
Gross Profit	4.44B
Operating Income	921.54M
Pretax Income	616.63M
Net Income	433.52M
EBITDA	1.23B
EBIT	921.54M
Earnings Per Share (EPS)	3.21

Balance Sheet

The company has 221.44 million in cash and 9.41 billion in debt, with a net cash position of -9.18 billion.

Cash & Cash Equivalents	221.44M
Total Debt	9.41B
Net Cash	-9.18B
Net Cash Per Share	n/a
Equity (Book Value)	-712.87M
Book Value Per Share	-8.87
Working Capital	873.84M

Cash Flow

In the last 12 months, operating cash flow was 462.47 million and capital expenditures -285.32 million, giving a free cash flow of 177.15 million.

Operating Cash Flow	462.47M
Capital Expenditures	-285.32M
Free Cash Flow	177.15M
FCF Per Share	n/a

Margins

Gross margin is 41.72%, with operating and profit margins of 8.67% and 4.08%.

Gross Margin	41.72%
Operating Margin	8.67%
Pretax Margin	5.80%
Profit Margin	4.08%
EBITDA Margin	11.58%
EBIT Margin	8.67%
FCF Margin	1.67%

Dividends & Yields

FRA:CG5 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.20%
Shareholder Yield	-2.20%
Earnings Yield	107.17%
FCF Yield	43.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:CG5 has an Altman Z-Score of 0.95 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.95
Piotroski F-Score	8